CTLA4 as Immunological Checkpoint in the Development of Multiple

4.5 (241) ·

$ 0.50 ·

In stock

Description

Current progress and prospect of immune checkpoint inhibitors in

TIGIT, a CTLA4-esque Immune Checkpoint for Cancer

Fighting against cancer with innovative immune checkpoint therapy

CHECKPOINT INHIBITORS - Novel Targets & Global Markets

Targeted Immunotherapies: Monoclonal Antibodies, Checkpoint

The expression and immunoregulation of immune checkpoint molecule

PD-1 and CTLA-4 immune checkpoints and immune checkpoint

Removing IL-6 from the mix prevents toxicity and boosts efficacy

Natural killer cells and immune-checkpoint inhibitor therapy

Immune checkpoint assays